Evonik Industries AG (EVKn)

Currency in EUR
18.380
-0.080(-0.43%)
Closed·
Trading near 52-week High
High dividend Yield
EVKn is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
18.35018.630
52 wk Range
12.49018.630
Key Statistics
Prev. Close
18.38
Open
18.47
Day's Range
18.35-18.63
52 wk Range
12.49-18.63
Volume
907.08K
Average Volume (3m)
1.26M
1-Year Change
8.3088%
Book Value / Share
16.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVKn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.277
Downside
-0.56%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Evonik Industries AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
5 Hold
4 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 18.277
(-0.56% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Sell15.50-15.67%15.00MaintainAug 10, 2026
Deutsche Bank
Hold18.00-2.07%17.00MaintainAug 10, 2026
Morgan Stanley
Buy21.00+14.25%19.00MaintainJul 20, 2026
UBS
Hold16.00-12.95%14.00MaintainJul 06, 2026
Goldman Sachs
Hold19.00+3.37%20.00DowngradeJun 08, 2026

Evonik Industries AG Earnings Call Summary for Q2/2026

  • Adjusted EBITDA rose 24% YoY to EUR 630M in Q2, Evonik's strongest quarter in four years, driven equally by volume and price gains.
  • Full-year 2026 adjusted EBITDA guidance midpoint raised by EUR 250M; Q3 expected strong with methionine as main driver before Q4 normalization.
  • Restructuring program targets 2,800 job cuts by end-2026, with 700 already completed; about 60% from administrative functions, 40% operational.
  • Stock gained 2.76% to $18.075, trading near 52-week high of $18.25, reflecting investor confidence in improved earnings momentum and outlook.
  • Management expects full-year cash conversion around 40% with higher absolute cash generation; divestitures of Oxeno and SYNEQT remain on schedule.
Last Updated: 2026-08-04, 05:58 a/m
Read Full Transcript

Earnings

Latest Release
Aug 04, 2026
EPS / Forecast
0.65 / 0.52
Revenue / Forecast
3.89B / 3.73B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.26%
Dividend Yield
5.44%
Industry Median 2.26%
Annualized payout
1.00
Paid annually
5-Years Growth
-2.76%
Growth Streak

EVKn Income Statement

Compare EVKn to Peers and Sector

Metrics to compare
EVKn
Peers
Sector
Relationship
P/E Ratio
70.8x20.2x4.4x
PEG Ratio
−0.99−0.970.00
Price/Book
1.1x1.7x1.6x
Price / LTM Sales
0.6x0.9x1.3x
Upside (Analyst Target)
3.4%9.5%36.3%
Fair Value Upside
Unlock8.5%1.9%Unlock

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.

Industry
Chemicals
Employees
30356
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
112.59M24.16%2.07B
Other Institutional Investors
226.50M48.61%4.16B
Public Companies & Retail Investors
126.91M27.23%2.33B
Total
466M100.00%8.57B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
RAG-Stiftung46.00%214,360,0003,939,937
Mondrian Investment Partners Limited5.00%23,297,313428,205

People Also Watch

38.880
NDXG
+0.99%
42.9900
GASI
+0.35%
41.10
KGX
+3.97%
36.70
8TRA
+0.11%

FAQ

What Is the Evonik (EVKn) Stock Price Today?

The Evonik stock price today is 18.380 EUR.

What Stock Exchange Does Evonik Trade On?

Evonik is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Evonik?

The stock symbol for Evonik is "EVKn."

Does Evonik Pay Dividends? What’s The Current Dividend Yield?

The Evonik dividend yield is 5.44%.

What Is the Evonik Market Cap?

As of today, Evonik market cap is 8.600B EUR.

What Is Evonik's Earnings Per Share (TTM)?

The Evonik EPS (TTM) is 0.260.

When Is the Next Evonik Earnings Date?

Evonik will release its next earnings report on Nov 03, 2026.

From a Technical Analysis Perspective, Is EVKn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Evonik Stock Split?

Evonik has split 0 times.

How Many Employees Does Evonik Have?

Evonik has 30356 employees.

What is the current trading status of Evonik (EVKn)?

As of Aug 22, 2026, Evonik (EVKn) is trading at a price of 18.380 EUR, with a previous close of 18.380 EUR. The stock has fluctuated within a day range of 18.350 EUR to 18.630 EUR, while its 52-week range spans from 12.490 EUR to 18.630 EUR.

What Is Evonik (EVKn) Price Target According to Analysts?

The average 12-month price target for Evonik is 18.277 EUR, with a high estimate of 21 EUR and a low estimate of 14 EUR. 4 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an -0.56% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.